A Pilot Study of Xifaxan in Patients With Primary Sclerosing Cholangitis

Trial Profile

A Pilot Study of Xifaxan in Patients With Primary Sclerosing Cholangitis

Completed
Phase of Trial: Phase I

Latest Information Update: 08 May 2015

At a glance

  • Drugs Rifaximin (Primary)
  • Indications Bacterial infections; Primary sclerosing cholangitis
  • Focus Therapeutic Use
  • Most Recent Events

    • 11 Sep 2013 Last checked against Mayo Clinic record.
    • 11 Sep 2013 Planned End Date changed from 1 Dec 2013 to 1 Mar 2014 as reported by ClinicalTrials.gov record.
    • 11 Sep 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top